Covered recipient · General Payments record
MATTHEW JOSEPH BRUCE
Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease
General Payments · PY2022–2024
$1,865.68
- Reported across 39 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $553.63 | 15 |
| Education | $197.11 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Biosense Webster, Inc. | $197.11 | 2 |
| Amgen Inc. | $144.15 | 2 |
| CARDIVA MEDICAL, INC. | $140.12 | 6 |
| ABIOMED | $135.79 | 1 |
| PFIZER INC. | $62.85 | 3 |
| Ethicon US, LLC | $31.52 | 1 |
| Janssen Pharmaceuticals, Inc | $20.67 | 1 |
| Acerta Pharma LLC | $18.53 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABIOMED | $135.79 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142281951 | CMS |
| Amgen Inc. | $129.53 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115465961 | CMS |
| Amgen Inc. | $14.62 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115465969 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.53 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104522850 | CMS |
| Biosense Webster, Inc. | $164.97 | 07/16/2024 | Education | Undisputed | 01/23/2026 | 1077676932 | CMS |
| Biosense Webster, Inc. | $32.14 | 08/08/2024 | Education | Undisputed | 01/23/2026 | 1077677094 | CMS |
| CARDIVA MEDICAL, INC. | $6.03 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143853188 | CMS |
| CARDIVA MEDICAL, INC. | $39.95 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143853190 | CMS |
| CARDIVA MEDICAL, INC. | $44.00 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143853192 | CMS |
| CARDIVA MEDICAL, INC. | $14.19 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143853194 | CMS |
| CARDIVA MEDICAL, INC. | $22.52 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143853196 | CMS |
| CARDIVA MEDICAL, INC. | $13.43 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143853198 | CMS |
| Ethicon US, LLC | $31.52 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077630378 | CMS |
| Janssen Pharmaceuticals, Inc | $20.67 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078004050 | CMS |
| PFIZER INC. | $17.85 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131601384 | CMS |
| PFIZER INC. | $27.12 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131246836 | CMS |
| PFIZER INC. | $17.88 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131601388 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.